213 related articles for article (PubMed ID: 34996123)
41. A novel splice mutation induces exon skipping of the EXT1 gene in patients with hereditary multiple exostoses.
Guo X; Lin M; Yan W; Chen W; Hong G
Int J Oncol; 2019 Mar; 54(3):859-868. PubMed ID: 30664192
[TBL] [Abstract][Full Text] [Related]
42. Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.
Mundy C; Yang E; Takano H; Billings PC; Pacifici M
J Biol Chem; 2018 May; 293(20):7703-7716. PubMed ID: 29622677
[TBL] [Abstract][Full Text] [Related]
43. Mutational screening of EXT1 and EXT2 genes in Polish patients with hereditary multiple exostoses.
Jamsheer A; Socha M; Sowińska-Seidler A; Telega K; Trzeciak T; Latos-Bieleńska A
J Appl Genet; 2014 May; 55(2):183-8. PubMed ID: 24532482
[TBL] [Abstract][Full Text] [Related]
44. Osteochondromas: review of the clinical, radiological and pathological features.
Kitsoulis P; Galani V; Stefanaki K; Paraskevas G; Karatzias G; Agnantis NJ; Bai M
In Vivo; 2008; 22(5):633-46. PubMed ID: 18853760
[TBL] [Abstract][Full Text] [Related]
45. [From gene to disease; hereditary multiple exostoses].
Wuyts W; Bovée JV; Hogendoorn PC
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
[TBL] [Abstract][Full Text] [Related]
46. Identification of Novel EXT Mutations in Patients with Hereditary Multiple Exostoses Using Whole-Exome Sequencing.
Liang C; Wang YJ; Wei YX; Dong Y; Zhang ZC
Orthop Surg; 2020 Jun; 12(3):990-996. PubMed ID: 32293802
[TBL] [Abstract][Full Text] [Related]
47. Heparan sulfate abnormalities in exostosis growth plates.
Hecht JT; Hall CR; Snuggs M; Hayes E; Haynes R; Cole WG
Bone; 2002 Jul; 31(1):199-204. PubMed ID: 12110435
[TBL] [Abstract][Full Text] [Related]
48. Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.
Cao L; Liu F; Kong M; Fang Y; Gu H; Chen Y; Zhao C; Zhang S; Bi Q
Oncol Rep; 2014 Feb; 31(2):713-8. PubMed ID: 24297320
[TBL] [Abstract][Full Text] [Related]
49. Novel mutation in the EXT-1 gene in an Iranian family affected with hereditary multiple exostoses.
Foroughmand AM; Galehdari H; Rasouli M; Mohammadian G; Mohammadi M
Pak J Biol Sci; 2008 Apr; 11(7):1037-41. PubMed ID: 18810975
[TBL] [Abstract][Full Text] [Related]
50. One third of Japanese patients with multiple osteochondromas may have mutations in genes other than EXT1 or EXT2.
Kojima H; Wada T; Seki H; Kubota T; Wakui K; Fukushima Y
Genet Test; 2008 Dec; 12(4):557-61. PubMed ID: 18976157
[TBL] [Abstract][Full Text] [Related]
51. [A splicing mutation of EXT1 in a Chinese pedigree with hereditary multiple exostoses].
Wang W; Qiu ZQ; Song HM
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):174-80. PubMed ID: 24568913
[TBL] [Abstract][Full Text] [Related]
52. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.
Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M
J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672
[TBL] [Abstract][Full Text] [Related]
53. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
[TBL] [Abstract][Full Text] [Related]
54. Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells.
Wang Y; Yang X; Yamagata S; Yamagata T; Sato T
Mol Cell Biochem; 2013 Jan; 373(1-2):63-72. PubMed ID: 23054193
[TBL] [Abstract][Full Text] [Related]
55. Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency.
de Andrea CE; Zhu JF; Jin H; Bovée JV; Jones KB
J Pathol; 2015 Jun; 236(2):210-8. PubMed ID: 25644707
[TBL] [Abstract][Full Text] [Related]
56. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
Chen WC; Chi CH; Chuang CC; Jou IM
J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
[TBL] [Abstract][Full Text] [Related]
57. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
[TBL] [Abstract][Full Text] [Related]
58. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.
Reijnders CM; Waaijer CJ; Hamilton A; Buddingh EP; Dijkstra SP; Ham J; Bakker E; Szuhai K; Karperien M; Hogendoorn PC; Stringer SE; Bovée JV
Am J Pathol; 2010 Oct; 177(4):1946-57. PubMed ID: 20813973
[TBL] [Abstract][Full Text] [Related]
59. Large-scale mutational analysis in the EXT1 and EXT2 genes for Japanese patients with multiple osteochondromas.
Ishimaru D; Gotoh M; Takayama S; Kosaki R; Matsumoto Y; Narimatsu H; Sato T; Kimata K; Akiyama H; Shimizu K; Matsumoto K
BMC Genet; 2016 Mar; 17():52. PubMed ID: 26961984
[TBL] [Abstract][Full Text] [Related]
60. Shop talk: Sugars, bones, and a disease called multiple hereditary exostoses.
Roehl HH; Pacifici M
Dev Dyn; 2010 Jun; 239(6):1901-4. PubMed ID: 20503385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
